BIOMAT Database Logo BIOMAT Database Logo

[On various derivatives of mefenamic and flufenamic acids]. 1968

R Spanò, and R Marri

UI MeSH Term Description Entries
D008528 Mefenamic Acid A non-steroidal anti-inflammatory agent with analgesic, anti-inflammatory, and antipyretic properties. It is an inhibitor of cyclooxygenase. Apo-Mefenamic,Contraflam,Coslan,Dysman,Mefac,Mefacit,Mefenaminic Acid,Mefic,Nu-Mefenamic,PMS-Mefenamic Acid,Parkemed,Pinalgesic,Ponalar,Ponalgic,Ponmel,Ponstan,Ponstan Forte,Ponstel,Ponsyl,Pontal,Acid, Mefenamic,Apo Mefenamic,Nu Mefenamic,PMS Mefenamic Acid
D005439 Flufenamic Acid An anthranilic acid derivative with analgesic, anti-inflammatory, and antipyretic properties. It is used in musculoskeletal and joint disorders and administered by mouth and topically. (From Martindale, The Extra Pharmacopoeia, 30th ed, p16) Dignodolin,Acid, Flufenamic
D000813 Anilides Any aromatic amide obtained by acylation of aniline.
D000893 Anti-Inflammatory Agents Substances that reduce or suppress INFLAMMATION. Anti-Inflammatory Agent,Antiinflammatory Agent,Agents, Anti-Inflammatory,Agents, Antiinflammatory,Anti-Inflammatories,Antiinflammatories,Antiinflammatory Agents,Agent, Anti-Inflammatory,Agent, Antiinflammatory,Agents, Anti Inflammatory,Anti Inflammatories,Anti Inflammatory Agent,Anti Inflammatory Agents
D062367 ortho-Aminobenzoates Benzoic acids, salts, or esters that contain an amino group attached to carbon number 2 or 6 of the benzene ring structure. 2-Aminobenzoates,6-Aminobenzoates,Anthranilates,Anthranilic Acids,o-Aminobenzoates,o-Aminobenzoic Acids,ortho-Aminobenzoic Acids,6 Aminobenzoates,Acids, Anthranilic,Acids, o-Aminobenzoic,Acids, ortho-Aminobenzoic,o Aminobenzoates,o Aminobenzoic Acids,ortho Aminobenzoates,ortho Aminobenzoic Acids

Related Publications

R Spanò, and R Marri
[Pharmacological properties of a series of derivatives of mefenamic and flufenamic acids].
April 1971, Il Farmaco; edizione scientifica,
R Spanò, and R Marri
[Analytical reactions of mefenamic and flufenamic acids].
March 1969, Annales pharmaceutiques francaises,
R Spanò, and R Marri
Experimental observations on flufenamic, mefenamic, and meclofenamic acids. I. Pharmacology.
January 1966, Annals of physical medicine,
R Spanò, and R Marri
Experimental observations on flufenamic, mefenamic and meclofenamic acids. 3. Metabolic disposition.
January 1966, Annals of physical medicine,
R Spanò, and R Marri
Spectrophotometric method for the determination of flufenamic and mefenamic acids.
October 1987, The Analyst,
R Spanò, and R Marri
Modulation of glutamate and glycine transporters by niflumic, flufenamic and mefenamic acids.
October 2009, Neurochemical research,
R Spanò, and R Marri
Potentiation of large conductance KCa channels by niflumic, flufenamic, and mefenamic acids.
December 1994, Biophysical journal,
R Spanò, and R Marri
Experimental observations on flufenamic, mefenamic, and meclofenamic acids. IV. Toleration by normal human subjects.
January 1966, Annals of physical medicine,
R Spanò, and R Marri
Determination of flufenamic, meclofenamic and mefenamic acids by capillary electrophoresis using beta-cyclodextrin.
April 1998, Journal of chromatography. B, Biomedical sciences and applications,
R Spanò, and R Marri
Analysis of binary mixtures of flufenamic, meclofenamic and mefenamic acids by derivative synchronous fluorescence spectrometry.
November 1998, Talanta,
Copied contents to your clipboard!